The update of treatment strategies in pediatrics with generalized pustular psoriasis in China
- PMID: 37736368
- PMCID: PMC10509407
- DOI: 10.1002/ped4.12395
The update of treatment strategies in pediatrics with generalized pustular psoriasis in China
Abstract
Generalized pustular psoriasis (GPP) is a severe subtype of psoriasis, commonly combined with systemic inflammation. Gene mutations have been found to be associated with GPP and vary by ethnicity. Systemic treatments are usually required for the severity and potential complications of GPP. However, there is no common consensus in China, especially among pediatric patients, whose data are scarce. Acitretin, methotrexate, and cyclosporine are widely used in pediatrics with GPP, while the adverse effects should be highlighted. The emergence of different biological agents brings us into a new era. This article discusses the genetic background of Chinese patients and demonstrates the evidence of treatment in pediatrics with GPP.
Keywords: Generalized pustular psoriasis; Pediatrics; Treatment.
© 2023 Chinese Medical Association. Pediatric Investigation published by John Wiley & Sons Australia, Ltd on behalf of Futang Research Center of Pediatric Development.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources